In Association WithReception SponsorSilverBronzeBreakfast, Registration, Lanyard Break SponsorMeeting Bag SponsorEvent SponsorPlatinum Event PartnerEvent Partners

Life Sciences Conferences

The Burrill Personalized Medicine Meeting


Monday - September 27, 2010 – Day One
7:30 – 8:30 a.m.
Breakfast & Registration

8:30 – 9:45 a.m.
Welcome and Personalized Medicine Industry Update
An overview of the state of the personalized medicine industry in the context of a turbulent, challenging economy, and in the “post healthcare reform environment”
G. Steven Burrill, CEO, Burrill & Company (Confirmed)

9:45 – 10:00 a.m.
Company Presentation: XDx
Pierre Cassigneul, President and Chief Executive Officer, XDx (Confirmed)

10:00 – 10:15 a.m.
Company Presentation: Navia Systems
Beau Cronin, CEO, Navia Systems (Confirmed)

10:00 – 10:30 a.m.

10:30 – 11:45 a.m.
Panel: Has “Healthcare Reform” accelerated or decelerated the move to a more Personalized Medicine world?
Richard W. Barker, MD, Director General, Association of the British Pharmaceutical Industry (Confirmed)
David Lawrence, MD, Former Chairman & CEO, Kaiser Foundation Health Plan and Hospitals, Inc. (Confirmed)
Elizabeth Ofili, MD, Director and Principal Investigator, National Institutes of Health Clinical Research Center at Morehouse (Confirmed)
Moderator: Edward Abrahams, PhD, Executive Director, Personalized Medicine Coalition (Confirmed)

11:45 a.m. – 1:15 p.m.
‘Conversations with Experts’ Luncheon

1:15 – 2:15 p.m.
Keynote Presentation: “Where is Science taking us?”
Dr. George Poste, DVM, PhD, Chief Scientist, Complex Adaptive Systems Initiative; Regents' Professor and Del E. Webb Chair in Health Innovation, Arizona State University (Confirmed)
Introduced by: G. Steven Burrill, CEO, Burrill & Company (Confirmed)

2:15 – 3:30 p.m.
The Translational Challenge: Building the Scientific Infrastructure for Personalized Medicine
The Translational Challenge: Building the Scientific Infrastructure for Personalized Medicine
Geoffrey S. Ginsburg, MD, PhD, Director, IGSP Center for Genomic Medicine (Confirmed)
Myla Lai-Goldman, CEO, CancerGuide, Diagnostics, Inc. (Confirmed)
Nick Naclerio, SVP, Corporate & Venture Development, Illumina, Inc. (Confirmed)
Christopher A. Slapak, MD, Distinguished Lilly Scholar (Executive Director), Eli Lilly and Company (Confirmed)
Moderator: Huntington F. Willard, PhD, Director, Institute for Genome Sciences & Policy (Confirmed)

3:30 – 4:00 p.m.

4:00 – 5:00 p.m.
Panel: Discussion on Consumer Digital Health… What’s it all about?
Andrew M. Thompson Co-Founder, Chief Executive Officer, Proteus (Confirmed)
Don Jones, Vice President, Health & Life Sciences, Qualcomm (Confirmed)
Moderator: G. Steven Burrill, CEO, Burrill & Company (Confirmed)

5:00 p.m.
Meeting Wrap-Up (Day One)
G. Steven Burrill, CEO, Burrill & Company (Confirmed)

5:00 – 6:30 p.m.
Networking Reception

Tuesday - September 28, 2010 – Day Two
7:30 – 8:15 a.m.

8:15 – 8:30 a.m.
Company Presentation: Existence Genetics
Brandon Colby, CEO, Existence Genetics (Confirmed)

8:30 – 9:45 a.m.
Panel: Making the Personal Genome Measurable and Meaningful
Atul Butte, MD, PhD, Medical Informatics, Stanford University School of Medicine (Confirmed)
Amy L. McGuire, JD, PhD, Associate Director for Research in the Center for Medical Ethics and Health Policy, Baylor College of Medicine (Confirmed)
Joanna Mountain, PhD, Senior Director of Research, 23andMe, Inc. (Confirmed)
Eric E. Schadt, PhD, Chief Scientific Officer, Pacific Biosciences (Confirmed)
Dietrich Stephan, PhD, Founder, President and Chief Executive Officer, Ignite Institute (Confirmed)
Moderator: Geoffrey S. Ginsburg, MD, PhD, Director, IGSP Center for Genomic Medicine (Confirmed)

9:45 – 10:00 a.m.

10:00 – 11:15 a.m.
Panel: Globally, what’s really happening with Personalized Medicine?
Stephen Little, MD, Vice President of Personalized Healthcare, QIAGEN (Confirmed)
Tim Harris, PhD, Chief Technology Officer, SAIC-Frederick (Confirmed)
Gerald J McDougall, Partner, PricewaterhouseCoopers, LLP (Confirmed)
Carl Johan Sundberg MD, PhD, University Lecturer, Associate Professor Coordinator Science & Society at the President's office, Karolinska Institutet (Confirmed)
Mark P. Stevenson, President and Chief Operating Officer, Life Technologies (Confirmed)
Moderator: G. Steven Burrill, CEO, Burrill & Company (Confirmed)

11:15 a.m. – 12:15 p.m.
Panel: What Will it Take to Get Patients to Believe in Personalized Medicine and Medicine to Deliver?
Gregory J. Downing, DO, PhD, Senior Advisor and Director, Personalized Health Care Initiative within the Immediate Office of the Secretary, U.S. Department of Health and Human Services (Confirmed)
Scott Joy, MD, Medical Director, Duke University Medical Center (Confirmed)
Glenn D. Steele Jr., MD, PhD, President & Chief Executive Officer, Geisinger Health System (Confirmed)
Moderator: Bradford B. Walters, MD, PhD, MBA, Vice President & Chief Medical Officer, RTI International (Confirmed)

12:15 – 1:15 p.m.

1:15 – 2:15 p.m.
Panel: Can we Make Sense of the Recent Court Rulings and Develop Strategies for Protecting Personalized Medicine Innovations?
John J. Doll, Former Acting United States Under Secretary of Commerce for Intellectual Property and Acting director of the United States Patent and Trademark Office (USPTO) (Confirmed)
Kevin E. Noonan, PhD, JD, Partner, McDonnell Boehnen Hulbert & Berghoff (Confirmed)
Sandra Park, Attorney, ACLU Women's Rights Project (Confirmed)
Michael Shuster, PhD, JD, Partner and Co-chair of the Life Sciences Group, at Fenwick & West LLP (Confirmed)
Moderator: Kenneth Chahine, PhD, JD, Biotech Executive and Professor of Law, S.J. Quinney College of Law University of Utah (Confirmed)

2:15 – 2:45 p.m.
Meeting Wrap-Up
G. Steven Burrill, CEO, Burrill & Company (Confirmed)